Search research articles
Contact Us
Filters
Showing results (1-10 of 100) with videos related to
Page
of 10
Sort By:
Gastroenterology & Hepatology
|
October 1, 2011
Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease
Miles P Sparrow
Expert Opinion on Biological Therapy
|
March 21, 2017
Adalimumab in ulcerative colitis - efficacy, safety and optimization in the era of treat-to target
Miles P Sparrow
World Journal of Gastroenterology
|
November 4, 2024
Perianal Crohn's disease: Still more questions than answers
Akhilesh Swaminathan, Miles P Sparrow
Journal of Clinical Medicine
|
February 13, 2026
Therapeutic Drug Monitoring of the Subcutaneous Formulations of Infliximab and Vedolizumab-Current Knowledge and Future Directions
Ben Massouridis, Miles P Sparrow
The Mount Sinai Journal of Medicine, New York
|
February 8, 2007
Translational research in inflammatory bowel disease
Maria T Abreu, Miles P Sparrow
Frontiers in Medicine
|
February 18, 2020
A Personalized Approach to Managing Patients With an Ileal Pouch-Anal Anastomosis
Zaid S Ardalan, Miles P Sparrow
Revista De Gastroenterologia De Mexico
|
October 31, 2007
[The role of translational research in inflammatory bowel disease]
María T Abreu, Miles P Sparrow
Digestive Diseases and Sciences
|
October 19, 2020
Evolving Role of Thiopurines in Inflammatory Bowel Disease in the Era of Biologics and New Small Molecules
Anke L H Nguyen, Miles P Sparrow
Current Drug Targets
|
April 7, 2011
Thiopurine immunomodulators in ulcerative colitis: moving forward with current evidence
Richard J La Nauze, Miles P Sparrow
Expert Review of Gastroenterology & Hepatology
|
April 2, 2014
The role of thiopurine metabolite monitoring in inflammatory bowel disease
Lauren Beswick, Antony B Friedman, Miles P Sparrow
Page
of 10
Search research articles
Search
Showing results (1-10 of 100) with videos related to
Sort By:
Page
of 10
Gastroenterology & Hepatology
|
October 1, 2011
Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease
Miles P Sparrow
Expert Opinion on Biological Therapy
|
March 21, 2017
Adalimumab in ulcerative colitis - efficacy, safety and optimization in the era of treat-to target
Miles P Sparrow
World Journal of Gastroenterology
|
November 4, 2024
Perianal Crohn's disease: Still more questions than answers
Akhilesh Swaminathan, Miles P Sparrow
Journal of Clinical Medicine
|
February 13, 2026
Therapeutic Drug Monitoring of the Subcutaneous Formulations of Infliximab and Vedolizumab-Current Knowledge and Future Directions
Ben Massouridis, Miles P Sparrow
The Mount Sinai Journal of Medicine, New York
|
February 8, 2007
Translational research in inflammatory bowel disease
Maria T Abreu, Miles P Sparrow
Frontiers in Medicine
|
February 18, 2020
A Personalized Approach to Managing Patients With an Ileal Pouch-Anal Anastomosis
Zaid S Ardalan, Miles P Sparrow
Revista De Gastroenterologia De Mexico
|
October 31, 2007
[The role of translational research in inflammatory bowel disease]
María T Abreu, Miles P Sparrow
Digestive Diseases and Sciences
|
October 19, 2020
Evolving Role of Thiopurines in Inflammatory Bowel Disease in the Era of Biologics and New Small Molecules
Anke L H Nguyen, Miles P Sparrow
Current Drug Targets
|
April 7, 2011
Thiopurine immunomodulators in ulcerative colitis: moving forward with current evidence
Richard J La Nauze, Miles P Sparrow
Expert Review of Gastroenterology & Hepatology
|
April 2, 2014
The role of thiopurine metabolite monitoring in inflammatory bowel disease
Lauren Beswick, Antony B Friedman, Miles P Sparrow
Page
of 10